A daily dose of more than 4.7mg ‘significantly prolonged' survival time and also improved quality of life.
The latest UK research points to the potential benefits of medical cannabis in two long-term conditions.
Researchers evaluated the effect of recreational cannabis legalisation and retail sales on use of cannabis, tobacco, and alcohol.
Researchers analysed data from 4,744 US adults aged 45 and older.
Researchers have highlighted the need for greater public health messaging around the risks of cannabis use disorders.
Adam Kavalier PhD, scientific director of Anthera Pharmaceuticals, explores what we know about medical cannabis in the treatment of PTSD.
The first study of its kind has found cannabis to be beneficial in the treatment of female orgasm disorder.
PTSD symptoms significantly reduced three months after starting treatment with cannabis-based medicines.
It is the first randomised trial to examine how legal, commercially available cannabis impacts anxiety symptoms.
A notable reduction in crystal meth use was observed among those who used cannabis for craving management.
